Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wayne

Showing results (351-360 of 400) with videos related to

Pageof 40
Sort By:
American Journal of Medical Genetics|July 23, 1998
Localization of a novel gene for nonsyndromic hearing loss (DFNB17) to chromosome region 7q31J H Greinwald, S Wayne, A H Chen, et al.
Cancers|September 12, 2017
The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALLEtai Adam, Hye Na Kim, Eun Ji Gang, et al.
Leukemia|October 20, 2006
Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphomaT Ise, S Nagata, R J Kreitman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignanciesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Genome Research|October 1, 1995
An autosomal recessive nonsyndromic form of sensorineural hearing loss maps to 3p-DFNB6K Fukushima, A Ramesh, C R Srisailapathy, et al.
Blood Advances|August 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALLColleen Annesley, Adam Lamble, Corinne Summers, et al.
Blood|July 5, 2011
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiencyRobert Sokolic, Irina Maric, Chimene Kesserwan, et al.
Blood|January 18, 2018
A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortiumWeili Sun, Timothy Triche, Jemily Malvar, et al.
Blood|December 18, 2012
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemiaWaleed Haso, Daniel W Lee, Nirali N Shah, et al.
Journal of Medicinal Chemistry|June 27, 2003
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonistJames B Thomas, Robert N Atkinson, N Ariane Vinson, et al.
Pageof 40

Showing results (351-360 of 400) with videos related to

Sort By:
Pageof 40
American Journal of Medical Genetics|July 23, 1998
Localization of a novel gene for nonsyndromic hearing loss (DFNB17) to chromosome region 7q31J H Greinwald, S Wayne, A H Chen, et al.
Cancers|September 12, 2017
The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALLEtai Adam, Hye Na Kim, Eun Ji Gang, et al.
Leukemia|October 20, 2006
Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphomaT Ise, S Nagata, R J Kreitman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignanciesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Genome Research|October 1, 1995
An autosomal recessive nonsyndromic form of sensorineural hearing loss maps to 3p-DFNB6K Fukushima, A Ramesh, C R Srisailapathy, et al.
Blood Advances|August 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALLColleen Annesley, Adam Lamble, Corinne Summers, et al.
Blood|July 5, 2011
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiencyRobert Sokolic, Irina Maric, Chimene Kesserwan, et al.
Blood|January 18, 2018
A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortiumWeili Sun, Timothy Triche, Jemily Malvar, et al.
Blood|December 18, 2012
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemiaWaleed Haso, Daniel W Lee, Nirali N Shah, et al.
Journal of Medicinal Chemistry|June 27, 2003
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonistJames B Thomas, Robert N Atkinson, N Ariane Vinson, et al.
Pageof 40